Skip to main content

Table 3 Hazard ratios for composite primary end point (crude vs. adjusted models)

From: Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial)

 

Hazard Ratio (95% CI)

p- value*

Crude

0.42 (0.18 - 0.96)

0.04

Model a

0.43 (0.19 - 0.99)

0.05

Model b

0.33 (0.13 - 0.80)

0.02

Model c

0.31 (0.12 - 0.78)

0.01

  1. * P-values calculated with cox proportional hazard regression analysis.
  2. Model a; adjusted for DM, hypertension, hypercholesterolemia, current smoking, family history of CAD, Model b; adjusted for clinical history (angina, myocardial infarction, PCI or CABG) and medication use at baseline (aspirin, beta-blokker, Ca-inhibitor, statins, ACE-I and AT II antagonist), Model c; adjusted for all covariates used in model a and b
Back to article page

Trials

ISSN: 1745-6215